Rotella Capital Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Rotella Capital Management’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-4,367	Closed	-$85K	–	770
2015 Q2	$85K	Buy	+4,367	New	+$84.3K	0.07%	301
2015 Q1	–	Sell	-2,659	Closed	-$63K	–	684
2014 Q4	$63K	Buy	+2,659	New	+$61.5K	0.05%	284
2014 Q3	–	Sell	-1,980	Closed	-$56K	–	491
2014 Q2	$56K	Buy	+1,980	New	+$59.5K	0.05%	299
2013 Q4	–	Sell	-1,090	Closed	-$18K	–	176
2013 Q3	$18K	Sell	1,090 -1,610	-60%	-$18.7K	0.03%	128
2013 Q2	$28K	Buy	+2,700	New	+$31.6K	0.09%	122

Other funds holding CTIC

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

LOAMU

Lombard Odier Asset Management (USA) New York $727M AUM 41.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Rotella Capital Management's CTIC Position: Q3 2015 in Review

Rotella Capital Management sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q3 2015, closing a stake of 4,367 shares — an estimated $85K sold.

Rotella Capital Management first reported a position in CTIC in Q2 2013 and held it in 5 quarters. The position peaked at $85K in Q2 2015. 86 funds tracked by Wall St. Rank hold CTIC as of Q3 2015.

Rotella Capital Management reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q3 2015 after selling out during the quarter.
Rotella Capital Management sold 4,367 CTI BioPharma Corp. (DE) Common Stock shares in Q3 2015, an estimated $85K.
Rotella Capital Management first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2013 and held it in 5 quarters.
Rotella Capital Management's CTI BioPharma Corp. (DE) Common Stock position peaked at $85K in Q2 2015.
86 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q3 2015.

Based on Rotella Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.